Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer | MicrobiomeTrials← Back to trialsNCT07195734
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-04-24Est. Completion: 2033-02-01
Enrollment target: 180 participants Locations- Banner University Medical Center - Tucson, Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
- USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto, Palo Alto, California, United States
- Sutter Medical Center Sacramento, Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
- Emory Proton Therapy Center, Atlanta, Georgia, United States
- Emory University Hospital Midtown, Atlanta, Georgia, United States
- Northwestern University, Chicago, Illinois, United States
- Rush MD Anderson Cancer Center, Chicago, Illinois, United States
- Carle at The Riverfront, Danville, Illinois, United States
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States
- Carle Physician Group-Effingham, Effingham, Illinois, United States
- Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States
- Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois, United States
- Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois, United States
- Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States
- Rush MD Anderson Cancer Center at Rush Lisle, Lisle, Illinois, United States
- Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States
- Northwestern Medicine Oak Brook, Oak Brook, Illinois, United States
- Northwestern Medicine Orland Park, Orland Park, Illinois, United States
- Memorial Hospital East, Shiloh, Illinois, United States
- Carle Cancer Center, Urbana, Illinois, United States
- Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States
- Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa, United States
- Iowa Methodist Medical Center, Des Moines, Iowa, United States
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States
- Broadlawns Medical Center, Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines, Des Moines, Iowa, United States
- UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States
- UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States
- University of Kansas Cancer Center, Kansas City, Kansas, United States
- University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States
- University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States
- LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, United States
- Our Lady of the Lake Physician Group, Baton Rouge, Louisiana, United States
- Our Lady of The Lake, Baton Rouge, Louisiana, United States
- Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States
- University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
- University of Michigan - Brighton Center for Specialty Care, Brighton, Michigan, United States
- Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States
- Henry Ford Hospital, Detroit, Michigan, United States
- Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States
- University of Mississippi Medical Center, Jackson, Mississippi, United States
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States
- Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
- University of Kansas Cancer Center - Briarcliff, Kansas City, Missouri, United States
- University of Kansas Cancer Center - North, Kansas City, Missouri, United States
- University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Siteman Cancer Center-South County, St Louis, Missouri, United States
- Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha, Nebraska, United States
- Nebraska Methodist Hospital, Omaha, Nebraska, United States
- Cooper Hospital University Medical Center, Camden, New Jersey, United States
- Jersey City Medical Center, Jersey City, New Jersey, United States
- Cooperman Barnabas Medical Center, Livingston, New Jersey, United States
- Monmouth Medical Center, Long Branch, New Jersey, United States
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
- Rutgers New Jersey Medical School, Newark, New Jersey, United States
- Community Medical Center, Toms River, New Jersey, United States
- Stony Brook University Medical Center, Stony Brook, New York, United States
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
- Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States
- Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina, United States
- ProMedica Flower Hospital, Sylvania, Ohio, United States
- University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
- Clackamas Radiation Oncology Center, Clackamas, Oregon, United States
- Legacy Mount Hood Medical Center, Gresham, Oregon, United States
- Providence Newberg Medical Center, Newberg, Oregon, United States
- Providence Willamette Falls Medical Center, Oregon City, Oregon, United States
- Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States
- Providence Portland Medical Center, Portland, Oregon, United States
- Providence Saint Vincent Medical Center, Portland, Oregon, United States
- Legacy Meridian Park Hospital, Tualatin, Oregon, United States
- UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States
- Saint Vincent Hospital, Erie, Pennsylvania, United States
- UPMC Cancer Center at UPMC Horizon, Farrell, Pennsylvania, United States
- IRMC Cancer Center, Indiana, Pennsylvania, United States
- Jefferson Hospital, Jefferson Hills, Pennsylvania, United States
- UPMC-Johnstown/John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania, United States
- Forbes Hospital, Monroeville, Pennsylvania, United States
- UPMC Cancer Center - Monroeville, Monroeville, Pennsylvania, United States
- UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania, United States
- Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
- Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
- UPMC-Saint Margaret, Pittsburgh, Pennsylvania, United States
- UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
- UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, United States
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, United States
- UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania, United States
- UPMC Cancer Center-Washington, Washington, Pennsylvania, United States
- UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania, United States
- Wexford Health and Wellness Pavilion, Wexford, Pennsylvania, United States
- Asplundh Cancer Pavilion, Willow Grove, Pennsylvania, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
- Legacy Cancer Institute Medical Oncology and Day Treatment, Vancouver, Washington, United States
- Legacy Salmon Creek Hospital, Vancouver, Washington, United States
- University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek, Wisconsin, United States
- Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
- Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States
- Medical College of Wisconsin, Milwaukee, Wisconsin, United States
- Froedtert and MCW Moorland Reserve Health Center, New Berlin, Wisconsin, United States
- Drexel Town Square Health Center, Oak Creek, Wisconsin, United States
- Froedtert West Bend Hospital/Kraemer Cancer Center, West Bend, Wisconsin, United States
Other microbiome trials you might be interested in
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell CarcinomaLocally Recurrent Hypopharyngeal Squamous Cell CarcinomaLocally Recurrent Laryngeal Squamous Cell CarcinomaLocally Recurrent Oral Cavity Squamous Cell CarcinomaLocally Recurrent Oropharyngeal Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell CarcinomaMetastatic Laryngeal Squamous Cell CarcinomaMetastatic MelanomaMetastatic Oral Cavity Squamous Cell CarcinomaMetastatic Oropharyngeal Squamous Cell CarcinomaRecurrent MelanomaStage III Hypopharyngeal Carcinoma AJCC v8Stage III Laryngeal Cancer AJCC v8Stage III Lip and Oral Cavity Cancer AJCC v8Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage IV Hypopharyngeal Carcinoma AJCC v8Stage IV Laryngeal Cancer AJCC v8Stage IV Lip and Oral Cavity Cancer AJCC v8Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8Unresectable Melanoma
This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in tr…
Phoenix, United StatesEst. completion Jan 1, 2027
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell CarcinomaOral Cavity Squamous Cell CarcinomaOropharyngeal Squamous Cell CarcinomaPathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Squamous Cell Carcinoma of Unknown PrimaryStage III Hypopharyngeal Carcinoma AJCC v8Stage III Laryngeal Cancer AJCC v8Stage III Lip and Oral Cavity Cancer AJCC v8Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage IVA Hypopharyngeal Carcinoma AJCC v8Stage IVA Laryngeal Cancer AJCC v8
Stage IVA Lip and Oral Cavity Cancer AJCC v8
Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVB Hypopharyngeal Carcinoma AJCC v8
Stage IVB Laryngeal Cancer AJCC v8
Stage IVB Lip and Oral Cavity Cancer AJCC v8
Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
This phase II/III trial studies how well radiation therapy works with durvalumab or cetuximab in treating patients with …
Birmingham, United StatesCompleted Sep 20, 2022